|
|
Article: Takeda Pharmaceuticals North America to Expand Sales Force.
- Article from:
- PR Newswire
- Article date:
- December 10, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LINCOLNSHIRE, Ill. -- Takeda Pharmaceuticals North America, Inc. (TPNA) today announced that it plans to expand its sales force to a total of 1,000 representatives. This new total represents an increase of 180 sales representatives. Takeda plans to have all new hires in place by January 1, 2002.
"The success of our oral anti-diabetes drug ACTOS(R) (pioglitazone HCl) has fueled our rapid growth," said Mark Booth, executive vice president at TPNA. "We are pleased to add to the size and scope of an already excellent sales force. We are proud that Takeda Pharmaceuticals has made a significant mark by serving so many patients since the introduction of ACTOS in ...
Related newspaper, magazine, and journal articles:
|
|
Article: Takeda Pharmaceuticals North America Names ...
PR Newswire;
November 22, 2005 ;
700+ words
... ... 22 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. (TPNA ... Booth, president of Takeda Pharmaceuticals North America. "We're ... Chicago School of Law. Takeda Pharmaceuticals North America, Inc. Based ...
|
|